The risks of ischemic and hemorrhagicstroke and poor neurological outcomes after stroke are increased in people with type 2 diabetes. Explore how to manage the hyperacute stroke stage and CV disease prevention.
STEP-HFpEF trial findings indicate that weekly semaglutide improves heart failure symptoms, physical limitations, and body weight in people with obesity-related heart failure and type 2 diabetes.
The Improving Diabetes Steering Committee outlines the place, value, and advantages of SGLT2 inhibitors in the treatment of type 2 diabetes. With user-friendly tools to support their use.
This UK consensus guideline provides a practical approach to the assessment and management of type 2 diabetes and associated complications in children and young people.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
HC-HB is a rare movement disorder that can occur in patients with poorly controlled diabetes and hyperglycemia without ketoacidosis. The mainstay of treatment is prompt correction of hyperglycemia.
Diabetic radiculoplexus neuropathy, or Bruns–Garland syndrome, is a rare form of microvascular complication that more commonly affects the lumbosacral plexus and, very rarely, the cervical plexus.
This case indicates that capillary blood glucose monitoring should be used alongside intermittently scanned CGM when pregnancy is complicated by type 1 diabetes and CKD.
With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report.
The time for diabetic nephropathy (DN) to progress from mild to severe is long. Thus, methods to continuously repress DN are required to exert long-lasting effects mediated through epigenetic regulation. In this study, we demonstrated the ability …
Diabetes is a chronic systemic metabolic disorder that emerges when there is inadequate insulin secretion or when the cells are unable to effectively utilize insulin for the metabolism of sugar [ 1 ]. The global prevalence of diabetes mellitus (DM) …
Diabetic retinopathy has a high probability of causing visual impairment or blindness throughout the disease progression and is characterized by the growth of new blood vessels in the retina at an advanced, proliferative stage. Microglia are a …
Diabetic neuropathy is a complication of diabetes mellitus that results from the metabolic and vascular disturbances associated with diabetes. It has been shown that up to 50–66% of all diabetic patients develop some sort of diabetic neuropathy …
An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.
Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.
This program is not available to users in the UK and US.
An independent educational program featuring simulated patient consultations. Make knowledge-based decisions on diagnosis and management of CKD with and without co-morbidities, and learn from experts Kevin Fernando and David Wheeler.
Diabetic retinopathy (DR) is the leading cause of blindness in working-age adults in the USA [ 1 ]. However, the risk of vision loss from DR can be reduced through early detection and management of blood sugar and blood pressure levels, as well as …
Among the various complications associated with diabetes, diabetic foot ulcer (DFU) has emerged as a significant contributor to both disability and mortality. The prevalence of DFU among individuals aged 50 years and above in China is alarmingly …
Limb loss is the most feared complication of diabetes, and foot ulceration its most common antecedent. Quality of diabetic foot disease care has therefore often been assessed by comparing amputation rates between services and between countries.
Diabetes mellitus affects 463 million people worldwide and this number is projected to rise to 700 million by 2045, making it a major global epidemic [ 1 ]. In the UK, 4.9 million individuals have diabetes, with £10 billion annually allocated by …
